What Researchers Did
Researchers conducted a review of existing literature focusing on the use of hyperbaric oxygen therapy as an additional treatment for osteonecrosis of the jaw.
What They Found
The review explored the basic and clinical science supporting hyperbaric oxygen therapy for osteonecrosis of the jaw, a condition that can result from radiation, medication, or infection. It also discussed ongoing controversies in the field and the economic considerations related to this treatment approach.
What This Means for Canadian Patients
For Canadian patients experiencing osteonecrosis of the jaw, this review highlights hyperbaric oxygen therapy as a potential adjunctive treatment option within a multimodal approach. It underscores the importance of discussing all available therapies, including surgery and HBOT, with healthcare providers to develop a comprehensive treatment plan.
Canadian Relevance
While this study does not have direct Canadian authors or affiliations, it covers osteonecrosis, including osteoradionecrosis, which is a Health Canada-recognized indication for hyperbaric oxygen therapy. The findings are therefore relevant to Canadian patients experiencing this condition.
Study Limitations
As a review article, this study synthesizes existing literature and does not present new primary research data or clinical trial outcomes.